PreveCeutical Medical Inc. (CSE:PREV)
Canada
· Delayed Price · Currency is CAD 0.0350
+0.0100 (40.00%)
May 13, 2025, 9:59 AM EDT
PreveCeutical Medical Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 0.06 | 0 | 0.01 | 0.02 | 0.16 | Upgrade
|
| Cash & Short-Term Investments | 0.06 | 0 | 0.01 | 0.02 | 0.16 | Upgrade
|
| Cash Growth | 4029.82% | -74.54% | -64.99% | -89.73% | 449.30% | Upgrade
|
| Other Receivables | 0.03 | 0.01 | 0.02 | 0.05 | 0.09 | Upgrade
|
| Receivables | 0.03 | 0.01 | 0.02 | 0.05 | 0.09 | Upgrade
|
| Prepaid Expenses | 0.03 | 0.06 | 0.04 | 0.01 | 0.02 | Upgrade
|
| Other Current Assets | - | - | - | - | 0 | Upgrade
|
| Total Current Assets | 0.12 | 0.06 | 0.06 | 0.08 | 0.26 | Upgrade
|
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0.01 | Upgrade
|
| Other Intangible Assets | 0.11 | 0.12 | 0.12 | 0.08 | 0.02 | Upgrade
|
| Other Long-Term Assets | - | - | - | - | 0.01 | Upgrade
|
| Total Assets | 0.23 | 0.18 | 0.19 | 0.16 | 0.3 | Upgrade
|
| Accounts Payable | 0.91 | 0.58 | 0.37 | 0.38 | 0.15 | Upgrade
|
| Accrued Expenses | 1.49 | 1.49 | 1.16 | 0.95 | 0.75 | Upgrade
|
| Short-Term Debt | 4.4 | 3.83 | 3.23 | 1.25 | 1.14 | Upgrade
|
| Current Portion of Long-Term Debt | - | 0.06 | 0.06 | - | - | Upgrade
|
| Total Current Liabilities | 6.8 | 5.96 | 4.82 | 2.59 | 2.03 | Upgrade
|
| Long-Term Debt | 0.06 | - | - | 1.68 | 1.88 | Upgrade
|
| Total Liabilities | 6.86 | 5.96 | 4.82 | 4.27 | 3.91 | Upgrade
|
| Common Stock | 19.59 | 19.31 | 19.31 | 18.56 | 17.57 | Upgrade
|
| Retained Earnings | -29.56 | -28.41 | -27.26 | -28.53 | -26.92 | Upgrade
|
| Comprehensive Income & Other | 3.33 | 3.32 | 3.32 | 5.86 | 5.75 | Upgrade
|
| Shareholders' Equity | -6.64 | -5.78 | -4.64 | -4.1 | -3.6 | Upgrade
|
| Total Liabilities & Equity | 0.23 | 0.18 | 0.19 | 0.16 | 0.3 | Upgrade
|
| Total Debt | 4.46 | 3.89 | 3.29 | 2.93 | 3.01 | Upgrade
|
| Net Cash (Debt) | -4.4 | -3.89 | -3.29 | -2.91 | -2.86 | Upgrade
|
| Net Cash Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Filing Date Shares Outstanding | 565.37 | 539.9 | 535.3 | 523.3 | 511.7 | Upgrade
|
| Total Common Shares Outstanding | 543.7 | 535.3 | 535.3 | 511.7 | 492.15 | Upgrade
|
| Working Capital | -6.68 | -5.9 | -4.76 | -2.51 | -1.77 | Upgrade
|
| Book Value Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Tangible Book Value | -6.74 | -5.89 | -4.76 | -4.18 | -3.63 | Upgrade
|
| Tangible Book Value Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Machinery | 0.02 | 0.02 | 0.02 | 0.02 | 0.05 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.